On Oct 5, 2021 IOmx Therapeutics closed a Series B round and raised €65,000,000 from ATHOS Service, M Ventures, MIG, Sofinnova Partners, Wellington Partners, featuring lead investors ATHOS Service, MIG.

About the company: IOmx Therapeutics is located at Germany, Europe.
“We discover and develop next-generation targeted immunotherapy treatments for cancer patients. antibody, cancer, signaling cascades, shut-down, immune-break”

Company website: http://www.iomx.com